Therapeutic Indications
CORBEVAX® is indicated for active immunization against Covid-19 disease in individuals aged 12 years and above in India.
CORBEVAX® is also indicated as a booster dose at ≥3 months after completion of primary immunization with 2 doses of Covishield or Covaxin or Corbevax in individuals aged 18 years and above. The vaccine is approved for restricted use in emergency situation.
Posology:
CORBEVAX® vaccination course consists of two separate doses of 0.5 mL. The second dose should be administered at least 4 weeks after the first dose. The vaccine should be administered intramuscularly in the deltoid muscle of upper arm.
Your email address will not be published. Required fields are marked *